Pacific Biosciences of California Investor Relations Material
Latest events
Q3 2024
Pacific Biosciences of California
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Pacific Biosciences of California Inc
Access all reports
Segment Data
Access more data
Revenue by
Products and services
Consumable
Instrument
Service and other
Expenses by
Financials
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT™) Sequencing platform enables single molecule real-time detection of biological processes. Its SMRT Sequencing technology provides various applications, including de novo sequencing to assemble a genome from scratch; targeted sequencing to sample specific regions of interest; and epigenetic sequencing to study how environmental factors affect gene expression. It has collaboration with Cold Spring Harbor Laboratory to expand its efforts in developing third-generation DNA sequencing technology.
Key slides for Pacific Biosciences of California Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Pacific Biosciences of California Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Pacific Biosciences of California Inc
Latest articles
Prada: The Story of an Icon
Prada's journey from a small Milan boutique to a global luxury empire, led by Miuccia's innovation and creativity.
5 Dec 2024
Hims & Hers: Bridging Gaps in Telehealth
Hims & Hers was founded in 2016 by Andrew Dudum and has grown into a ~$4 billion company in the telehealth industry in less than a decade.
5 Dec 2024
Andrew Dudum: Founder and CEO of Hims & Hers
Andrew Dudum is the founder and CEO of Hims & Hers, an innovative telehealth company focused on bridging the gap between consumers and healthcare.
4 Dec 2024
Ticker symbol
PACB
Country
🇺🇸 United States